Maa: Australia
Kieli: englanti
Lähde: Department of Health (Therapeutic Goods Administration)
Insulin aspart
Novo Nordisk Pharmaceuticals Pty Ltd
Medicine Registered
NovoRapid ® Penfill ® Page 1 of 6 NovoRapidPfcmi14.doc NOVORAPID ® PENFILL ® _Insulin aspart (rys) _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET WHAT NOVORAPID ® IS USED FOR.. 1 BEFORE YOU USE NOVORAPID ® PENFILL ® ....................................... 1 HOW TO USE NOVORAPID ® PENFILL ® 2 WHILE YOU ARE USING NOVORAPID ® PENFILL ® ....................................... 4 THINGS TO BE CAREFUL OF ............. 5 SIDE EFFECTS................................. 5 AFTER USING NOVORAPID ® PENFILL ® 6 PRODUCT DESCRIPTION ................. 6 FURTHER INFORMATION ................ 6 This leaflet answers some common questions about NovoRapid ® Penfill ® . It does not contain all the available information. It does not take the place of talking to your doctor, diabetes education nurse or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using NovoRapid ® Penfill ® against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR, DIABETES EDUCATION NURSE OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT NOVORAPID ® IS USED FOR The insulin aspart, or “NovoRapid ® ”, in NovoRapid ® Penfill ® is a rapid-acting insulin used to treat diabetes mellitus in adults and children. Diabetes mellitus is a condition where your pancreas does not produce enough insulin to control your blood sugar (glucose) level. Extra insulin is therefore needed. There are two types of diabetes mellitus: Type 1 diabetes – also called juvenile onset diabetes Type 2 diabetes – also called maturity onset diabetes Patients with type 1 diabetes always require insulin to control their blood sugar levels. Some patients with type 2 diabetes may also require Lue koko asiakirja